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Introduction
Liver transplantation (LT) restores people’s lives; however, 
cardiometabolic risk factors are increasingly impacting 
on survival (1), with a higher prevalence of cardiovascular 
events in liver transplant recipients (LTR) compared to the 
general population (2). These risk factors include obesity, 
new onset diabetes and the metabolic syndrome (1,3). In 
addition, obesity increases hepatic steatosis and recurrence 
or de novo non-alcoholic fatty liver disease (NAFLD). This 
may contribute to the severity of other recurrent diseases 
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such as hepatitis C (4-6). Early identification, prevention 
and management of post-transplant obesity may positively 
impact on these liver related issues and the development of 
co-morbidities, which in turn may impact long-term post-
transplant survival (7).
Obesity in adult post-LTRs appears to be a world-wide 
phenomenon (7) and affects more than 20% of patients 
in the first year after transplantation (8-10). Weight gains 
of approximately 10% dry body weight are observed at 
6 months post-transplant, and gradually increase to ~20% 
by 3 years (9). However, there is little data as to what 
proportion is due to replenishment of muscle mass, or the 
accumulation of fat stores (11). 
There is also a paucity of data regarding the changes in 
dietary intake and habits post-transplant, for example food 
group intake and snacking and in particular the impact of 
psychological factors such as recovering from a period of 
significant illness coupled with intrusive dietary restriction; 
and surviving a life-threatening disease which may influence 
eating behaviour.
There are limited guidelines to inform diet and exercise 
advice beyond the immediate period post liver transplant, 
whether these are general recommendations, specific to 
the obese patient; or for the management of recurrent 
disease such as hepatic steatosis. The American Society of 
Transplantation and the United Network for Organ Sharing 
provide some lifestyle recommendations, albeit brief and 
generic, for hypertension and diabetes management post 
solid organ transplant (12,13).
With these issues in mind, the aim of the study was 
to prospectively assess changes in weight, nutritional 
status, body composition, dietary intake and psychological 
characteristics including perceived stress and depressive 
symptoms in patients before and at 6 and 12 months post 
liver transplant.
Methods
This single-centre prospective observational cohort study 
was commenced in March 2012, at the Princess Alexandra 
Hospital (PAH), within the Queensland Liver Transplant 
Service. Ethical approval was obtained from the PAH 
Human Research Ethics Committee (approval number 
HREC/12/QPAH/81-SSA/12/QPAH/97). Informed 
consent in writing was obtained from the each patient.
Subject recruitment
Patients awaiting liver transplant were invited to participate 
in the study during the recruitment phase from March 
2012 to June 2013. Eleven patients received a transplant 
prior to being approached for inclusion in the study and 
were not included in the observations. All patients who 
were approached to participate following active listing 
(n=27) consented to the study but only those transplated by 
December 2014 (n=17) were included in the 6 and 12 month 
post-transplant assessment (see Figure 1).
Medical history
Patient medical history including age, gender and peri-
operative complications, aetiology of liver disease and 
Model for End-stage Liver Disease (MELD) score were 
collected from the medical chart and the hospital liver 
transplant database and the primary indication for liver 
transplant was assessed by a consultant gastroenterologist.
Anthropometry and nutritional status
Weight and waist circumference were measured at 6 and 
12 months post-transplant. Due to the presence of ascites 
in some patients pre-transplant, a dry weight measured at 
one month post-transplant was used as baseline weight for 
all patients to calculate baseline body mass index (BMI) 
Figure 1 Flowchart of prospective cohort from consent on the 
liver transplant waiting list to 12 months post-transplant follow-up.
Consented on liver 
transplant waitlist
n=27
Removed waiting list
n=4
Remained on waiting  
list at study end
n=6
Underwent pre-transplant 
(baseline) assessment
 n=23
Received a liver transplant
n=17
Completed 6-month  
follow-up 
n=17
Completed 12-month  
follow-up 
n=17
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and weight change by 6 and 12 months post-transplant. 
Percentage body fat was assessed using bioelectrical 
spectroscopy (ImpediMed SBF7, Impedimed, Australia; 
normal range males 8% to 24%, females 21% to 35%) (14). 
Subjective global assessment (SGA) (15) was used to assess 
nutritional status at pre-transplant and at 6 and 12 months. 
Hand grip strength (HGS) was also assessed at the three 
time points as a mean of both hands using an electronic 
dynamometer (Camry model: EH101; normal HGS males 
≥30 kg and females ≥20 kg) (16). An oral glucose tolerance 
test was performed by Queensland Health Pathology at 
6 months, as part of standard clinical practice at this centre. 
Physical activity
Physical activity was assessed pre-transplant and 6 months 
post-OLT using the International Physical Activity 
Questionnaire-Short Form (17). The questionnaire 
incorporates seven items to assess varying intensities of physical 
activity that include walking, moderate physical activity, 
vigorous physical activity, and sitting, reported as metabolic 
equivalent task score per week (METS-minutes/week).
Dietary assessment
Usual dietary intake data were collected via an in-depth diet 
history, where the participants’ self-recorded usual intake 
of food and beverages consumed over a seven day period. 
The record was validated by an interview with an accredited 
practicing dietitian, which involved quantification of portion 
sizes and where possible, capturing brand names. Dietary 
data were collected pre-transplant, and at 6 and 12 months 
post-transplant by the same research dietitian. These data 
were analysed using FoodWorks 7® Professional (Xyris 
Software, Australia) using the NUTTAB 2010 database to 
determine average daily energy, protein, and sodium intakes 
and percentage energy contribution from macronutrients 
(carbohydrate, fat, protein). Energy and protein requirements 
were calculated for each study participant based on 
the ESPEN guidelines for nutrition in liver disease and 
transplantation (18). Pre-transplant requirements were 
calculated as 147–168 kJ/kg of adjusted body weight/day 
and 1.2–1.5 g protein/kg of adjusted body weight/day. The 
respective energy and protein requirements post-transplant 
were 100–125 kJ/kg of adjusted body weight/day and 0.8– 
1.0 g/kg of adjusted body weight/day (19). For overweight 
or obese patients an adjusted body weight was used for all 
calculations [adjusted body weight = (ideal body weight at 
BMI 25 kg/m2 ×0.025) + ideal body weight at BMI 25 kg/m2] 
and reported as kJ/kg of adjusted body weight and g/kg of 
adjusted body weight. Participants were considered energy 
under-reporters if the energy intake to basal metabolic rate 
ratio was below 0.9 (20).
Food group analysis was performed for the diets of 
each participant using the latest Australian food-nutrient 
databases, AUSNUT 2011–2013 (21). In this database each 
food is allocated a unique code, which is used to group 
foods into 24 major food groups. Food intake of the study 
participants was compared with the national medians as 
reported in National Nutrition and Physical Activity Survey, 
Australian Health Survey (AHS) (22). 
Psychological factors
Responsiveness to the food environment was assessed 
pre-transplant and at 6 months post-transplant using the 
validated 15-item Power of Food Scale (23,24). Patients 
answered on a 5-point Likert scale (ranging from 1= don’t 
agree, to 5= strongly agree), to assess the psychological 
impact of a food-abundant environment, with a higher 
score indicating a stronger appetitive drive. Perceived stress, 
depressive symptoms, self-esteem levels, and disordered 
food habits such as night snacking were assessed using the 
Weight and Lifestyle Inventory (WALI) (25).
Statistical analyses
Participant characteristics are reported as mean ± standard 
deviation or median [interquartile range (IQR)] depending 
on the distribution of the data. Repeated measures ANOVA 
(continuous variables), with post-hoc Tukey’s test, or 
Friedman Test, and Cochran’s Q (categorical variables) were 
used to identify differences in variable between the three 
time points. Paired t-test or Wilcoxon Signed rank test were 
used for continuous and categorical variables, respectively, 
when data from only two time points were available. 
Comparison of food group intake with the Australian 
population and between 6 months post-transplant and 
12 months post-transplant were assessed using Mann-
Whitney Test and Wilcoxon Signed Rank Test, respectively. 
Spearman’s rho was used to assess the association between 
HGS and percentage body fat mass. Statistical significance 
was reached when P<0.05 and all statistical analyses were 
conducted in Statistical Package for the Social Sciences 
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(SPSS®) Version 22 (IBM Corporation). Cases with missing 
data were excluded from their related analyses.
Results
Pre-transplant characteristics
Figure 1 outlines the number of participants invited and 
recruited in this prospective study. Of the 27 participants 
consented to the study, four were removed from the liver 
transplant list prior to pre-transplant assessment (n=3 
for disease progression and n=1 due to improvement 
in liver function). Twenty-three participants [6 women 
(median age, 49 years) and 17 men (median age, 53 years)] 
underwent pre-transplant assessment; however six were still 
awaiting LT when recruitment ended. Seventeen orthotopic 
liver transplantations (OLT) were performed [median 
age 54 years (IQR 16 years), males n=14], with a median 
waiting time of 12 months (range, 4 to 30 months) between 
listing and transplant. The study cohort was representative 
of all patients active on the waiting list between 2011 and 
2012 in age (P=0.48), gender (P=0.76) and MELD score 
(P=0.97). 
The median MELD score was 15. Six patients had a 
MELD score of less than 15. Three of these were suffering 
recurrent bouts of cholangitis requiring intravenous 
antibiotics and hospital admission, two with previous Kasai 
procedures as neonates and a third with PSC (MELDs 6, 
7 and 13 respectively). One patient had suffered a hepatic 
artery thrombosis after previous liver transplant for chronic 
HBV and now had recurrent sepsis (MELD 12). A fifth 
patient had high output cardiac failure related to hereditary 
haemorrhagic telangiectasia with the vascular abnormalities 
largely confined to the liver (MELD 8); while the final 
patient had liver disease from HCV and alcohol with 
intractable hepatic encephalopathy (MELD 13). Three 
patients had small HCCs, only one with a diameter >2.0 cm, 
and their calculated MELDs were 15, 16 and 17.
A standard triple therapy calcineurin inhibitor 
immunosuppression regime was employed, with steroid 
induction. Post-OLT all participants went on tacrolimus, 
azathioprine, and prednisolone, with the azathioprine and 
prednisolone generally weaned after 3 months (only one 
patient remained on prednisolone by 6 months post-OLT). 
Serum tacrolimus levels were maintained at an average of 
8.2 μg/L (range, 5.5–16.6) at 6 months post-transplant and 
6.6 μg/L (range, 3.0–9.9) at 12 months post-transplant. 
Six participants had peri-operative complications (such as 
rejection and infection) but did not differ in age, gender or 
BMI from those without such complications. 
Change in nutritional status
Mean weight at the three time points is presented in Table 1 
and BMI change over 12 months is illustrated in Figure 2. 
Weight change was variable, but on average participants 
gained 7.3% (95% CI, 2.2% to 14.2%) of body weight by 
12 months post-OLT with the majority of the weight gain 
[6.4% (95% CI, 1.7% to 12.2%)] occurring within 6 months 
of transplant. This led to an increase in those classified 
as overweight or obese, from a baseline of 53% (n=9/17) 
to 77% (n=13/17) by 12 months-post OLT (Figure 2). 
Eight participants (47%) were malnourished (SGA-B) pre-
transplant. This resolved within 6 months of transplant, 
with all patients classified as well-nourished (SGA-A) 
through to 12 months post-OLT. Handgrip strength was 
32.9±5.4 kg in males and 22.1±2.5 kg in females pre-
transplant and was not correlated with age (P=0.31). 
Reduced muscular strength, [as classified by HGS <30 kg 
males and <20 kg females (16)], was present in 4 patients 
pre-transplant and this persisted at 12 months in 3 patients 
despite these individuals experiencing weight gain ranging 
from 6.5 to 23.3 kg and being overweight or obese at 
12 months. There was a negative correlation between HGS 
and body fat percentage (r=−0.67, P=0.012). There was no 
relationship between initial BMI and amount of weight gain 
(P=0.96).
There was no change in overall median physical activity 
after transplant [790 MET-minute/week (IQR 243-2098 
MET-minute/week) vs. 956 MET-minute/week (IQR 
604-6021MET-minute/week), P=0.124]. However, within 
the categories of exercise intensity, there was a 50% increase 
in walking activity reported by 6 months post-transplant 
[429 MET-minutes/week (IQR 50-644 MET-minutes/
week) vs. 644 MET-minutes/week (IQR 446-2079 MET-
minutes/week), P=0.028] and no change in moderate or 
vigorous activities. 
Oral glucose tolerance test at 6 months post-OLT 
revealed 65% (n=11/17) of patients had altered glucose 
metabolism (new onset diabetes n=7; persistent pre-existing 
diabetes n=1; impaired glucose tolerance n=3).
Dietary characteristics 
One participant was excluded from the dietary analyses due 
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to under-reporting, defined by the Goldberg cut-off (20). 
Table 1 shows nutrient intake at the three time points and 
the proportion of patients below, meeting, or exceeding 
their estimated energy needs pre- and post-OLT. At 6 
months post-OLT there was substantial variation in those 
below, meeting and exceeding energy requirements. This 
appeared to resolve by 12 months post-transplant with the 
majority meeting their energy needs. Once transplanted, 
Table 1 Differences in participants’ characteristics and nutrient intake between baseline (pre-transplant), 6-, and 12-month post-transplant  
(mean ± SD)
Characteristics (N=17) Baseline (pre-transplant) 6 months 12 months P value#
Weight, kga,** 78.0±12.3 83.0±20.2* 83.7±19.5* 0.008
BMI, (kg/m2)b,** 26.4±4.9 28.1±5.2* 28.6±5.5* 0.001
Waist, cm NA 100.0±15.1 99.7±14.1 0.760
Body fat, % NA 35.1±13.1 33.1±9.2 0.183
Fat free mass, % NA 67.6±8.7 66.4±9.0 0.804
Hand grip strength, kg 31.2±6.3 33.5±7.4 34.3±7.6* 0.030
Diabetes status (yes), % [n] 5.9 [1] 47.1 [8] NA 0.50
Energy intake (kJ/d) 9,444±2,535 8,460±1,917 8,583±1,645 0.415
Energy intake (kJ/kg/d)c,d 150±46 133±31 138±23 0.242
Energy requirementse, % [n]
Below requirements (yes) 25.0 [4] 31.3 [5] 6.3 [1] 0.197
Meeting requirements (yes) 62.5 [10] 37.5 [6] 75.0 [12] 0.097
Exceeding requirements (yes) 12.5 [2] 31.3 [5] 18.8 [3] 0.472
Protein intake (g/kg/d)c,d 1.7±0.5 1.6±0.4 1.6±0.5 0.590
Protein requirementse, % [n]
Below requirements (yes) 12.5 [2] 0 0 0.135
Meeting requirements (yes) 31.3 [5] 0*** 6.7 [1] 0.015
Exceeding requirements (yes) 56.3 [9] 100 [16]*** 93.3 [15]*** 0.002
Average carbohydrate intake (g/day)c 281±78 208±49* 235±36**** 0.002
Fibre intake (g/day)c 26±11 24±9 29±10 0.745
Total fat intake (g/day)c 73±28 70±27 70±24 0.682
Average fat intake (% energy/day)c 31±9 29±16 31±16 0.511
Average saturated fat intake (g/day) 32±15 23±23 27±28 0.558
Average saturated fat intake (% energy/day) 13±3 12±5* 12±7* 0.223
Average sodium intake (mg/day)c 2,207±632 2,495±605 2,599±748 0.231
aBaseline weight assessed at 1 month post-transplant as a dry weight; bbaseline BMI calculated with dry weight 1 month post-transplant; 
cn=16, as 1 participant was excluded due to over-reporting food intake; denergy intake (kJ) or protein intake (g) per kilogram of adjusted 
body weight (kg) for overweight and obese participants; epre-transplant energy and protein requirements were calculated using an actual 
weight (adjusted for overweight and obese participants); #P value reported for multivariate comparison between the three time points; 
*P<0.05 when compared with baseline measure using post-hoc Tukey’s test; **P<0.01 when compared with baseline measure using post-
hoc Tukey’s test; ***P<0.05 when compared with baseline measure using Cochran’s Q test; ****P<0.05 when compared with carbohydrate 
intake at six months post-transplant. SD, standard deviation; BMI, body mass index; NA, not available.
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no significant changes were observed in protein intake over 
a period of 12 months. Despite a measurable increase in 
carbohydrate intake between 6 and 12 months post-OLT, 
intake of carbohydrates remained significantly lower than 
that recorded pre-transplant. Sodium intake remained that 
of a ‘no added salt’ diet (i.e., <100 mmol/day).
Specific food group analysis indicated that during the 
course of transplant recovery, the intake of carbohydrate-
rich food groups such as ‘Cereal-based products and dishes’ 
(including sweet pastries, cakes, and pies), ‘Cereal products 
and dishes’ (such as breads, pasta, breakfast cereals), and 
‘Vegetables’ (including sweet corn and potatoes) increased 
(Table 2). Compared to the general Australian population, 
LTRs consumed less refined carbohydrates, less fish/
seafood, and more vegetables and dairy products (Table 2). 
There was a sustained avoidance of eggs during the whole 
12 months post-OLT period. The intake of sugar sweetened 
beverages and sugar products and dishes post transplant was 
also low. 
Psychological factors
The impact of behavioural and emotional factors typically 
associated with excess weight such as stress levels, presence 
of depressive symptoms, self esteem and appetitive drive 
associated with food experience and dietary behaviours 
was assessed by questionnaire. At 6 months post-OLT, 
more than half the patients (56%, n=9/16) perceived low to 
average levels of stress during the last 6 months and most 
(81%, n=13/16) anticipated similar levels of stress in the 
next 6 months. Over half of the patients (69%, n=11/16) 
reported low to no depressive feelings and rated their self-
esteem as good (53%, n=9/16) or average (31%, n=5/16). 
Night snacking, i.e., waking up from sleep to eat, was 
present in 75% of patients’ pre-transplant and only 25% 
6 months post-OLT. The Power of Food Scale increased 
from pre-transplant to 6 months after transplant, which was 
comparable to that of an obese population with diabetes (22), 
indicating a stronger appetitive drive (1.6±0.5 vs. 1.9±0.4, 
P=0.028).
Discussion
This descriptive longitudinal study identified significant 
weight gain (6.4% of body weight on average) in the 
first six months following LT. By 12 months post-OLT, 
patients had gained on average 7.3% of body weight. 
Furthermore, two-thirds of transplant recipients had 
evidence of impaired glucose metabolism by 6 months post-
OLT. Replenishing muscle stores is an anticipated (26), 
beneficial consequence of liver transplant, and there was 
evidence of improved muscle function with improvement 
in HGS (mean 3.1 kg by 12 months post-transplant). 
However, by 6 months, two out of every three patients were 
centrally obese, indicating unhealthy fat deposition. Once 
present post-OLT, excess body fat persists long term (11). 
Thus the current study highlights the early onset of fat 
accumulation and implies there should be early steps to 
identify and address post-OLT obesity. 
Retrospective studies have identified larger weight 
gains post-OLT (10–20% within the first year) (8-10). 
However, the weight gain in this study is in agreement with 
a prospective cohort study of 597 LTRs (5.1 kg in the first 
year post-OLT) (8). 
Previous studies have examined weight gain in relation 
to risk factors such as age, aetiology of liver disease and 
type of immunosuppression (8,9,11). Corticosteroids 
have well-recognised effects on appetite and weight gain 
(12,13), however in our centre there is a strategy to try to 
wean prednisolone by three months and only one patient 
remained on this (at 5 mg/d) at six months. 
The return of a normal diet and appetite have also been 
implicated as contributors to weight gain post-OLT (8,27), 
yet this is the first study to report on the dietary patterns 
and diet quality in this unique patient population, using 
robust prospective dietary assessment methods. When 
compared to the Australian adult population, LTRs had 
similar intakes of meat, fruit, and oils, and a high saturated 
fat intake, consistent with a Western-style dietary pattern, 
but lower intake of processed carbohydrate foods (cereal-
based products and dishes). By 12 months, patients were 
Figure 2 Change in percentage of patients within healthy, 
overweight and obese body mass index categories over a 12 months 
period.
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consuming more vegetables (equivalent to one additional 
serve per day) and had approximately 40% higher intakes 
of dairy products compared to population norms. There 
appeared to be a sustained avoidance of eggs and fish post-
transplant.
In general, patients with advanced liver disease 
awaiting transplant are prescribed a high protein, high 
energy, reduced sodium diet (28) to preserve muscle and 
fat stores and reduce fluid accumulation. To achieve this 
requires a high intake of dairy products and meats or meat 
alternatives. They are encouraged to eat frequent meals 
and have night-time snacks, evident in 75% of this sample 
pre-transplant (29).
Immuno-compromised patients, such as these in the 
acute OLT period, are considered at increased risk of food-
borne infections (30). While there is a lack of reliable 
data regarding the rates of post-transplant food-borne 
illness, a conservative dietary approach is often taken for 
these patients (30,31). This may explain the low intake of 
eggs and seafood in our patients compared to the general 
Australian population. Other dietary patterns post-OLT 
also appear to reflect pre-transplant advice, and whilst 
patients mostly cease night snacking, they maintain high 
protein intakes and a sodium intake two thirds that of the 
general population (32).
Obese LTRs are at increased risk of late complications 
such as hepatic steatosis, type 2 diabetes and post-transplant 
malignancies (33). After cardiovascular complications, 
de novo malignancies are the second leading cause of 
death in transplant recipients (33). Diabetes and poor 
glycaemic control are associated with adverse outcomes 
post transplant (34). Effective prevention and management 
of post-OLT co-morbidities may improve patient survival 
and quality of life. Lifestyle intervention, including physical 
activity and dietary pattern modification may mitigate risk 
of these post-OLT complications.
The Western-style dietary pattern observed may 
exacerbate these metabolic risk factors in the setting of 
obesity. A shift towards a Mediterranean-style diet has been 
shown to be beneficial in cardiovascular health, glycemic 
control, reducing hepatic steatosis and insulin resistance 
(35-37). The Mediterranean dietary pattern promotes 
plant-based foods, healthy fats (with emphasis on olive 
oil and nuts), limiting red and processed meat and dairy 
products and consuming fish regularly (38). Further studies 
investigating the potential beneficial effects of targeting key 
aspects of the Mediterranean dietary pattern (decreasing 
red meat and dairy; and increasing intake of fish, nuts, 
vegetables and unsaturated oils) are of interest in the LTR 
population. 
LTRs increased physical activity post-OLT, with a 
switch from predominantly sitting/sedentary activity 
pre-transplant to lightly active lifestyle post-transplant. 
This was not sufficient to ameliorate increased rates of 
Table 2 Food groups consumed by patients after OLT in comparison to the Australian population from the National Nutrition and Physical 
Activity Survey [median (IQR)] (22)
Food group
Australian population  
(≥19 years; 2011–2013)  
food consumption (g/day)
6 months post-OLT  
food consumption  
(g/day) (n=16)
12 months post-OLT  
food consumption  
(g/day) (n=16)
P value#
Cereals and cereal products 130 154 [84–200] 200 [150–285]* 0.028
Cereal-based products and dishes 175 68 [42–136]* 122 [55–195]* 0.011
Fruits (products and dishes) 191 185 [58–303] 184 [49–333] 0.910
Vegetables (products and dishes) 163 199 [89–319] 234 [134–344]* 0.049
Fats and oils 10 10 [1–17] 10 [5–19] 0.388
Dairy products and dishes 187 264 [153–642]* 418 [213–721]* 0.056
Egg products and dishes 78 0 [0–31]* 0 [0–11]* 0.028
Fish and seafood products and dishes 110 21 [0–29]* 21 [2–48]* 0.241
Meat and poultry products and dishes 174 154 [96–197] 128 [107–196] 0.438
*, P<0.05 when compared with intake of Australian population; #, P values are reported for comparison between food intake at 6 and  
12 months post-transplant. OLT, orthotopic liver transplantation; IQR, interquartile range.
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metabolic dysfunction or increases in fat mass. The negative 
correlation between change in HGS and fat mass suggests 
those that are gaining the fattest are also gaining least muscle 
quality. A greater intensity of physical activity is probably 
required to have benefits on metabolic dysfunction (39), 
and an early focus on achieving this appears warranted. 
HGS has been inversely associated with cardiovascular 
disease and cardiovascular mortality in the general 
population (40) and may be a valuable addition to standard 
post-transplant monitoring protocols to predict those at risk 
of adverse cardiovascular health long term.
This study assessed a number of behaviours and 
emotional factors typically associated with obesity; and 
hedonic characteristics associated with food experience in 
an obesogenic food environment. All but one patient met or 
exceeded predicted energy intake requirements at 12 months 
post-OLT. There was an increase in the Power of Food 
score after transplant suggesting that appetitive drive 
increases early and by 6 months is similar to that of an 
obese diabetic population (24). In other obese patient 
populations in a tertiary hospital setting, the prevalence 
of depressive symptoms is as high as 65% (41). Despite 
the increasing prevalence of overweight and obesity, 
LTRs report emotional factors and behaviours that are in 
significant contrast to this. In general most of our cohort 
had minimal to no depressive feelings; with healthy ratings 
for self-esteem and minimal evidence of disordered eating 
behaviours. This is of clinical importance when designing 
lifestyle interventions for this patient population.
This study had a number of l imitations. It  was 
underpowered to undertake multivariate analysis to 
explore the independent drivers for the variability of 
weight change observed (note large SD/95% CI). The 
disease etiology and time since diagnosis may impact on 
the results of this study, however with the small data set a 
sub group analysis is not appropriate. Immunosuppressive 
agents such as prednisolone and tacrolimus may impact on 
metabolism, however due to the small data set conclusions 
cannot be drawn regarding the impact of individual 
immunosuppressive agents or doses. The observational 
nature of the study cannot determine causation between 
dietary intake (i.e., amount and pattern), weight change 
and metabolic outcomes. Longer term cardiometabolic 
outcomes were not captured, however the finding that 
weight gain slows after the first 6 months post-OLT is 
clear. The investigators invested considerable attention 
to validating patient recall of dietary intake and physical 
activity data, however inherent limitations remain with 
reliance on self-reported data collection. Higher quality 
methods of assessing body composition such as CT or MRI 
may have improved the precision of the body fat data and 
should be considered for future studies, however the use 
of low cost, accessible methodologies such as BIA assist 
with real world translation of practice change. Finally, this 
work did not explore key drivers in dietary pattern choices, 
therefore can only hypothesize about legacy effect of dietary 
recommendations pre- and immediately post OLT.
While weight gain after transplantation is well 
documented, there is a gap in evidence-based lifestyle 
intervention to prevent and mitigate cardiometabolic risk 
factors in the first year post-OLT. In the current study, we 
show that excess weight gain occurs early post-transplant; 
is predominantly due to gain in fat mass; and is observed 
in concert with developed metabolic disturbances such as 
impaired glucose tolerance and diabetes. Part of the post-
transplant weight gain may relate to western style dietary 
patterns, continuation of pre-transplant food choices and 
low intensity physical activity. The emotional drivers and 
response to excess weight gain in OLT-recipients seem 
distinct from those seen in the general obese population. 
These data could inform strategies to address weight gain 
with the most obvious of these being that interventions to 
limit weight gain should occur early after LT and should be 
tailored to meet the characteristics of this unique patient 
population.
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